These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 18631209)
1. Fixed drug eruption mimicking supraumbilical skin rash: one of rare complication of transarterial chemoembolization. Lee E; Kim GM; Kim SY J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):324-5. PubMed ID: 18631209 [No Abstract] [Full Text] [Related]
2. A case of supraumbilical skin rash after chemoembolization for hepatocellular carcinoma. Byun JW; Han SH; Song HJ; Hong WK; Lee HS; Shin JH; Choi GS J Eur Acad Dermatol Venereol; 2009 Dec; 23(12):1458-9. PubMed ID: 19453804 [No Abstract] [Full Text] [Related]
3. Drug-eluting particles in the treatment of HCC: chemoembolization with doxorubicin-loaded DC Bead. Malagari K Expert Rev Anticancer Ther; 2008 Oct; 8(10):1643-50. PubMed ID: 18925855 [TBL] [Abstract][Full Text] [Related]
4. Out of control: hepatitis B reactivation by transarterial treatment of hepatocellular carcinoma. von Weizsäcker F; Blum HE J Hepatol; 2004 Sep; 41(3):482-4. PubMed ID: 15336452 [No Abstract] [Full Text] [Related]
5. Supraumbilical skin rash after chemoembolization for hepatocellular carcinoma. Hama Y; Iwasaki Y; Kusano S Eur Radiol; 2000; 10(8):1356. PubMed ID: 10939508 [No Abstract] [Full Text] [Related]
6. Simultaneous acral nodular eruption and flagellate erythema caused by bleomycin. Mikhail M; Eichenbaum M; Gerstenfeld E; Duquette J; Pomeranz MK; Polsky D J Drugs Dermatol; 2005; 4(1):81-4. PubMed ID: 15696989 [TBL] [Abstract][Full Text] [Related]
7. Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma. Li M; Lu C; Cheng J; Zhang J; Cao C; Xu J; Xu J; Pan H; Zhong B; Tucker S; Wang D J Gastroenterol Hepatol; 2009 Aug; 24(8):1437-44. PubMed ID: 19486255 [TBL] [Abstract][Full Text] [Related]
13. Chemotherapy-induced toxic erythema under treatment with pegylated liposomal doxorubicin: No restriction to palms and soles. Ziemer M; Goetze S; Kaatz M; Elsner P J Am Acad Dermatol; 2008 Feb; 58(2 Suppl):S44-6. PubMed ID: 18191705 [No Abstract] [Full Text] [Related]
14. Toxic erythema of chemotherapy: a useful clinical term. Bolognia JL; Cooper DL; Glusac EJ J Am Acad Dermatol; 2008 Sep; 59(3):524-9. PubMed ID: 18694683 [No Abstract] [Full Text] [Related]
15. Flagellate Pattern of Toxic Erythema of Chemotherapy Due to Doxorubicin: A Case Report. Vadeboncoeur S; Côté B J Cutan Med Surg; 2016 Sep; 20(5):481-3. PubMed ID: 27068228 [TBL] [Abstract][Full Text] [Related]
16. Pilot study of transarterial chemoembolization with pirarubicin and amiodarone for unresectable hepatocellular carcinoma. Guiu B; Colin C; Cercueil JP; Loffroy R; Guiu S; Ferrant E; Jouve JL; Bonnetain F; Boulin M; Ghiringhelli F; Minello A; Hillon P; Bedenne L; Krause D; Chauffert B Am J Clin Oncol; 2009 Jun; 32(3):238-44. PubMed ID: 19349854 [TBL] [Abstract][Full Text] [Related]
17. Abdominal rash after transarterial chemoembolization via the right inferior phrenic artery. Brennan DD; Farrelly C; Cooney R; Norris S; McEniff N J Vasc Interv Radiol; 2005 Sep; 16(9):1269. PubMed ID: 16151071 [No Abstract] [Full Text] [Related]
18. Fixed drug eruption induced by tipepidine hibenzate. Iwabuchi C; Kanto H; Ohashi N; Itoh M J Dermatol; 2010 May; 37(5):502-3. PubMed ID: 20536661 [No Abstract] [Full Text] [Related]
19. Cutaneous drug eruptions induced by sorafenib: a case series. Maddox JS; Kung EF; Petronic-Rosic V; Sethi A J Drugs Dermatol; 2008 Sep; 7(9):891-3. PubMed ID: 19112807 [TBL] [Abstract][Full Text] [Related]